Polymyalgia rheumatica

被引：14
作者：
Mackie, Sarah L. [1 ]
Mallen, Christian D. [2 ]
机构：
[1] Univ Leeds, Chapel Allerton Hosp, Natl Inst Hlth Res Leeds Musculoskeletal Biomed R, Leeds Inst Rheumat & Musculoskeletal Med, Leeds LS7 4SA, W Yorkshire, England
[2] Keele Univ, Arthrit Res UK Primary Care Ctr, Keele ST5 5BG, Staffs, England
来源：
BMJ-BRITISH MEDICAL JOURNAL | 2013年 / 347卷
关键词：
ERYTHROCYTE SEDIMENTATION-RATE; GIANT-CELL ARTERITIS; TEMPORAL ARTERITIS; DISEASE-ACTIVITY; FOLLOW-UP; CLASSIFICATION CRITERIA; PLASMA VISCOSITY; BHPR GUIDELINES; DOUBLE-BLIND; ONSET;
D O I：
10.1136/bmj.f6937
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页数：9
相关论文
共 66 条
[61]   Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica - A randomized trial [J].
Salvarani, Carlo ;
Macchioni, PierLuigi ;
Manzini, Carlo ;
Paolazzi, Giuseppe ;
Trotta, Aldo ;
Manganelli, Paolo ;
Cimmino, Marco ;
Gerli, Roberto ;
Catanoso, Maria Grazia ;
Boiardi, Luigi ;
Cantini, Fabrizio ;
Klersy, Catherine ;
Hunder, Gene G. .
ANNALS OF INTERNAL MEDICINE, 2007, 146 (09) :631-639
[62]   Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990-2001 [J].
Smeeth, L. ;
Cook, C. ;
Hall, A. J. .
ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (08) :1093-1098
[63]   The adrenal steroid status in relation to inflammatory cytokines (interleukin-6 and tumour necrosis factor) in polymyalgia rheumatica [J].
Straub, RH ;
Glück, T ;
Cutolo, M ;
Georgi, J ;
Helmke, K ;
Schölmerich, J ;
Vaith, P ;
Lang, B .
RHEUMATOLOGY, 2000, 39 (06) :624-631
[64]  
Strehl C, 2011, CLIN EXP RHEUMATOL, V29, pS13
[65]   Corticosteroid requirements in polymyalgia rheumatica [J].
Weyand, CM ;
Fulbright, JW ;
Evans, JM ;
Hunder, GG ;
Goronzy, JJ .
ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (06) :577-584
[66]  
Zacharski LR, 1976, BRIT J HOSP MED, V16, P53
1234567